Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Pediatric Gastroenterology and Nutrition|February 22, 2023
Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric-Onset IBD CohortJess L Kaplan, Chunyan Liu, Eileen C King, et al.
Plos Medicine|November 15, 2017
Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trialRita R Alloway, Alexander A Vinks, Tsuyoshi Fukuda, et al.
Childhood Obesity (Print)|August 26, 2024
Percent Body Fat and Weight Status of Youth Participating in Pediatric Weight Management Programs in the Pediatric Obesity Weight Evaluation RegistryMaheen Quadri, Adolfo J Ariza, Jared M Tucker, et al.
The Journal of Allergy and Clinical Immunology|June 4, 2011
Long-term outcomes in pediatric-onset esophageal eosinophiliaCharles W DeBrosse, James P Franciosi, Eileen C King, et al.
Pediatric Cardiology|January 30, 2013
Abnormal circumferential strain is present in young Duchenne muscular dystrophy patientsThomas D Ryan, Michael D Taylor, Wojciech Mazur, et al.
Human Mutation|January 4, 2020
Elucidation of de novo small insertion/deletion biology with parent-of-origin phasingAllison H Seiden, Felix Richter, Nihir Patel, et al.
American Heart Journal|February 26, 2022
Design and rationale for the supermarket and web-based intervention targeting nutrition (SuperWIN) for cardiovascular risk reduction trialSarah C Couch, Robert N Helsley, Francesca U Siegel, et al.
The Journal of Allergy and Clinical Immunology|July 13, 2010
Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999Charles W DeBrosse, Margaret H Collins, Bridget K Buckmeier Butz, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 31, 2022
Elevated blood pressure in youth in pediatric weight management programs in the Pediatric Obesity Weight Evaluation Registry (POWER)Helen J Binns, Madeline Joseph, Adolfo J Ariza, et al.
Journal of the American Heart Association|January 13, 2016
Digoxin Use Is Associated With Reduced Interstage Mortality in Patients With No History of Arrhythmia After Stage I Palliation for Single Ventricle Heart DiseaseDavid W Brown, Colleen Mangeot, Jeffrey B Anderson, et al.
Pageof 4